ASX - Delayed Quote AUD

PERCHERON FPO [PER] (PER.AX)

0.0100

0.0000

(0.00%)

At close: 11:10:18 AM GMT+10

3 Promising ASX Penny Stocks With Market Caps Over A$70M

The ASX200 is set to open 0.15% lower today, reflecting mixed performances among US markets, with notable movements in the Dow and tech sector fluctuations impacting investor sentiment. In such a climate, finding stocks with strong fundamentals can be crucial for investors seeking stability and growth potential. Penny stocks, though often overlooked due to their historical reputation, can offer significant opportunities when backed by solid financials; this article will explore three...

Simply Wall St. 6 months ago

BVSFF

PERCF

VLS.AX
Analysts Expect Breakeven For Percheron Therapeutics Limited (ASX:PER) Before Long

Percheron Therapeutics Limited ( ASX:PER ) is possibly approaching a major achievement in its business, so we would...

Simply Wall St. 7 months ago

ATHJF
Percheron Therapeutics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Percheron Therapeutics ( ASX:PER ) Full Year 2024 Results Key Financial Results Revenue: AU$2.97m (up 88% from FY...

Simply Wall St. 8 months ago

ATHJF
Investing in Percheron Therapeutics (ASX:PER) five years ago would have delivered you a 67% gain

Stock pickers are generally looking for stocks that will outperform the broader market. And while active stock picking...

Simply Wall St. 8 months ago

ATHJF
Here's Why We're Watching Percheron Therapeutics' (ASX:PER) Cash Burn Situation

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...

Simply Wall St. 11 months ago

ATHJF

Performance Overview

Return	PER.AX	S&P/ASX 200 [XJO] (^AXJO)
YTD	+42.86%	+2.79%
1-Year	-86.67%	+6.82%
3-Year	-82.46%	+17.37%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

PERCHERON FPO [PER] (PER.AX)

3 Promising ASX Penny Stocks With Market Caps Over A$70M

Analysts Expect Breakeven For Percheron Therapeutics Limited (ASX:PER) Before Long

Percheron Therapeutics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Investing in Percheron Therapeutics (ASX:PER) five years ago would have delivered you a 67% gain

Here's Why We're Watching Percheron Therapeutics' (ASX:PER) Cash Burn Situation

Performance Overview